Amplification and Enrichment Platforms for Liquid Biopsy-based Early Prognostication of Cancer, Canada

Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties
Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group
Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper

Registration Status: Completed

Objective: We will use blood samples from prostate cancer patients in a Canadian Cancer Society Innovation Grant project to amplify and enrich biomarkers for prognostication purposes. We aim to use blood samples collected through the APCaRI biobank: https://apcari.ca/our-research/biorepository/

Registered Biobank Name	Amplification and Enrichment Platforms for Liquid Biopsy-based Early Prognostication of Cancer
Biobank Leader	John Lewis, Roger Zemp
Country	Canada
Email for biobank inquiries	rzemp@ualberta.ca
Principal Investigator	Roger Zemp
User Type Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper

Biospecimen Collected: